A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era

British Journal of Haematology

Volumn 165, Issue 3, 2014, Pages 358-363

  Hosein, Peter J ^a   Maragulia, Jocelyn C ^b   Salzberg, Matthew P ^a   Press, Oliver W ^c   Habermann, Thomas M ^d   Vose, Julie M ^e   Bast, Martin ^e   Advani, Ranjana H ^f   Tibshirani, Robert ^g   Evens, Andrew M ^h   Islam, Nahida ^h   Leonard, John P ⁱ   Martin, Peter ⁱ   Zelenetz, Andrew D ^b   Lossos, Izidore S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c USA   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Breast; Central nervous system; Diffuse large B cell lymphoma; Lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM METASTASIS; DRUG MEGADOSE; FOLLOW UP; HUMAN; INTERNATIONAL PROGNOSTIC INDEX; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIMARY BREAST DIFFUSE LARGE B CELL LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

BREAST; CENTRAL NERVOUS SYSTEM; DIFFUSE LARGE B-CELL LYMPHOMA; LYMPHOMA; RITUXIMAB;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84898401574     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12753     Document Type: Article

References (19)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J. Jr, Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
2. Aviles, A., Delgado, S., Nambo, M.J., Neri, N., Murillo, E. & Cleto, S. (2005) Primary breast lymphoma: results of a controlled clinical trial. Oncology, 69, 256-260.
3. Aviles, A., Castaneda, C., Neri, N., Cleto, S. & Nambo, M.J. (2007) Rituximab and dose dense chemotherapy in primary breast lymphoma. Haematologica, 92, 1147-1148.
4. Aviles, A., Neri, N. & Nambo, M.J. (2012) The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast. American Journal of Clinical Oncology, 35, 126-129.
5. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. & Tubiana, M. (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Research, 31, 1860-1861.
6. Cheson, B.D., Horning, S.J., Coiffier, B., Shipp, M.A., Fisher, R.I., Connors, J.M., Lister, T.A., Vose, J., Grillo-Lopez, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N.L., Armitage, J.O., Carter, W., Hoppe, R. & Canellos, G.P. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. Journal of Clinical Oncology, 17, 1244.
7. Domchek, S.M., Hecht, J.L., Fleming, M.D., Pinkus, G.S. & Canellos, G.P. (2002) Lymphomas of the breast: primary and secondary involvement. Cancer, 94, 6-13.
8. Freeman, C., Berg, J.W. & Cutler, S.J. (1972) Occurrence and prognosis of extranodal lymphomas. Cancer, 29, 252-260.
9. Guirguis, H.R., Cheung, M.C., Mahrous, M., Piliotis, E., Berinstein, N., Imrie, K.R., Zhang, L. & Buckstein, R. (2012) Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature. British Journal of Haematology, 159, 39-49.
10. Habermann, T.M., Weller, E.A., Morrison, V.A., Gascoyne, R.D., Cassileth, P.A., Cohn, J.B., Dakhil, S.R., Woda, B., Fisher, R.I., Peterson, B.A. & Horning, S.J. (2006) Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. Journal of Clinical Oncology, 24, 3121-3127.
11. Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Muller-Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. & Chan, W.C. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275-282.
12. Held, G., Zeynalova, S., Murawski, N., Ziepert, M., Kempf, B., Viardot, A., Dreyling, M., Hallek, M., Witzens-Harig, M., Fleckenstein, J., Rube, C., Zwick, C., Glass, B., Schmitz, N. & Pfreundschuh, M. (2013) Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement. Journal of Clinical Oncology, 31, 4115-4122.
13. Jeanneret-Sozzi, W., Taghian, A., Epelbaum, R., Poortmans, P., Zwahlen, D., Amsler, B., Villette, S., Belkacemi, Y., Nguyen, T., Scalliet, P., Maingon, P., Gutierrez, C., Gastelblum, P., Krengli, M., Raad, R.A., Ozsahin, M. & Mirimanoff, R.O. (2008) Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study. BMC Cancer, 8, 86.
14. Jennings, W.C., Baker, R.S., Murray, S.S., Howard, C.A., Parker, D.E., Peabody, L.F., Vice, H.M., Sheehan, W.W. & Broughan, T.A. (2007) Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Annals of Surgery, 245, 784-789.
15. Miller, T.P., Dahlberg, S., Cassady, J.R., Adelstein, D.J., Spier, C.M., Grogan, T.M., LeBlanc, M., Carlin, S., Chase, E. & Fisher, R.I. (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. New England Journal of Medicine, 339, 21-26.
16. Ryan, G., Martinelli, G., Kuper-Hommel, M., Tsang, R., Pruneri, G., Yuen, K., Roos, D., Lennard, A., Devizzi, L., Crabb, S., Hossfeld, D., Pratt, G., Dell'Olio, M., Choo, S.P., Bociek, R.G., Radford, J., Lade, S., Gianni, A.M., Zucca, E., Cavalli, F. & Seymour, J.F. (2008) Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Annals of Oncology, 19, 233-241.
17. Wiseman, C. & Liao, K.T. (1972) Primary lymphoma of the breast. Cancer, 29, 1705-1712.
18. Yhim, H.Y., Kang, H.J., Choi, Y.H., Kim, S.J., Kim, W.S., Chae, Y.S., Kim, J.S., Choi, C.W., Oh, S.Y., Eom, H.S., Kim, J.A., Lee, J.H., Won, J.H., Shim, H., Lee, J.J., Sung, H.J., Kim, H.J., Lee, D.H., Suh, C. & Kwak, J.Y. (2010) Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; consortium for improving survival of lymphoma (CISL) study. BMC Cancer, 10, 321.
19. Zucca, E., Conconi, A., Mughal, T.I., Sarris, A.H., Seymour, J.F., Vitolo, U., Klasa, R., Ozsahin, M., Mead, G.M., Gianni, M.A., Cortelazzo, S., Ferreri, A.J., Ambrosetti, A., Martelli, M., Thieblemont, C., Moreno, H.G., Pinotti, G., Martinelli, G., Mozzana, R., Grisanti, S., Provencio, M., Balzarotti, M., Laveder, F., Oltean, G., Callea, V., Roy, P., Cavalli, F. & Gospodarowicz, M.K. (2003) Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. Journal of Clinical Oncology, 21, 20-27.